The Future of Gene Therapy for Ocular Conditions
Live Webinar Presented by Emerging Therapy Solutions®
Don't miss this free LIVE webinar
with Emerging Therapy Solutions® (ETS)!
Please join us for a live webinar with Dr. Cagri Besirli, MD, PhD, Associate Professor, Ophthalmology and Visual Sciences from the University of Michigan Kellogg Eye Center to learn about the gene therapy Luxturna®, as well as the future of gene therapy for ocular conditions.
Topics include:
- Overview of gene therapy for ocular conditions
- Overview of Luxturna, including the patient and clinical experience
- The successes and challenges related to gene therapy for ocular conditions
- The near-term future of gene therapy and what is coming
Webinar Date and Time: |
Thursday, January 6, 2022 10:00 AM – 11:00 AM CST
|
For more information please visit Emergingtherapies.com or call 877.445.4822
TMHCC is a leading provider of medical stop loss insurance provided through brokers, consultants and third-party administrators. By listening to the demands of the market, we have developed exceptional products, unparalleled resources and value-added services that set us apart in the industry. Visit our website to learn more about our innovative stop loss, Taft-Hartley, captive and organ transplant solutions.